|Title:||2020 Consensus summary on the management of hypertension in Asia from the HOPE Asia Network||Authors:||Kario K.
Van Minh H.
|Keywords:||ambulatory blood pressure monitoring; Asia; cardiovascular disease; guidelines; home blood pressure monitoring; hypertension||Issue Date:||2020||Publisher:||Blackwell Publishing Inc.||Journal Volume:||22||Journal Issue:||3||Start page/Pages:||351-362||Source:||Journal of Clinical Hypertension||Abstract:||
Hypertension professionals from Asia have been meeting together for the last decade to discuss how to improve the management of hypertension. Based on these education and research activities, the Hypertension, brain, cardiovascular and renal Outcome Prevention and Evidence in Asia (HOPE Asia) Network was officially established in June 2018 and includes experts from 12 countries/regions across Asia. Among the numerous research and review papers published by members of the HOPE Asia Network since 2017, publications in three key areas provide important guidance on the management of hypertension in Asia. This article highlights key consensus documents, which relate to the Asian characteristics of hypertension, home blood pressure monitoring (HBPM), and ambulatory blood pressure monitoring (ABPM). Hypertension and hypertension-related diseases are common in Asia, and their characteristics differ from those in other populations. It is essential that these are taken into consideration to provide the best opportunity for achieving “perfect 24-hour blood pressure control”, guided by out-of-office (home and ambulatory) blood pressure monitoring. These region-specific consensus documents should contribute to optimizing individual and population-based hypertension management strategies in Asian country. In addition, the HOPE Asia Network model provides a good example of the local interpretation, modification, and dissemination of international best practice to benefit specific populations. ? 2019 Wiley Periodicals, Inc.
|ISSN:||1524-6175||DOI:||10.1111/jch.13751||SDG/Keyword:||angiotensin receptor antagonist; calcium channel blocking agent; dipeptidyl carboxypeptidase inhibitor; diuretic agent; enkephalinase inhibitor; sodium glucose cotransporter 2 inhibitor; antihypertensive therapy; Asian; atrial fibrillation; blood pressure monitoring; blood pressure variability; cardiovascular disease; cerebrovascular accident; chronic kidney failure; comorbidity; heart failure; human; hypertension; kidney denervation; lifestyle modification; masked hypertension; morning hypertension; non insulin dependent diabetes mellitus; priority journal; Review; secondary prevention; white coat hypertension; Asia; blood pressure; blood pressure monitoring; consensus; hypertension; Asia; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Consensus; Humans; Hypertension
|Appears in Collections:||醫學系|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.